A Study to Evaluate MEDI0562 in Combination With Immune Therapeutic Agents in Adult Subjects With Advanced Solid Tumors

Clinical trial NCT02705482 · COMPLETED

Trial details

NCT number: NCT02705482
Sponsor: MedImmune LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Select Advanced Solid Tumors

Start date: 2016-03-30
Primary completion: 2019-08-07
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.